Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes

Jeroen de Bresser1, Yael D Reijmer, Esther van den Berg

  • 1Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands. J.deBresser@umcutrecht.nl

Abstract

Insights

In patients with type 2 diabetes mellitus (T2DM), albuminuria predicted faster cognitive decline over four years. Other microvascular complications like retinopathy or neuropathy did not show this association.

Area of Science:

  • Neurology
  • Endocrinology
  • Diabetology

Background:

  • Type 2 diabetes mellitus (T2DM) is associated with microvascular complications.
  • These complications may impact cognitive function and brain structure.
  • Longitudinal studies are needed to clarify these relationships.

Purpose of the Study:

  • To investigate the association between microvascular complications in T2DM and cognitive decline.
  • To examine the relationship between these complications and structural brain changes over four years.
  • To determine if diabetic retinopathy, peripheral neuropathy, or albuminuria predict cognitive decline or brain abnormalities.

Main Methods:

  • Sixty-eight elderly T2DM patients underwent two cognitive assessments over four years.
  • Brain MRI scans were analyzed for volumetric changes in total brain, ventricles, and white matter hyperintensities.
  • Linear regression analyses assessed the relationship between baseline microvascular complications and cognitive/brain changes.

Main Results:

  • Albuminuria was significantly associated with accelerated cognitive decline (p < 0.001).
  • Diabetic retinopathy and peripheral neuropathy were not significantly linked to cognitive decline or brain abnormalities.
  • No significant associations were found between microvascular complications and changes in brain volumes over time.

Conclusions:

  • Albuminuria is a predictor of accelerated cognitive decline in individuals with T2DM.
  • Other common microvascular complications, such as retinopathy and neuropathy, do not appear to influence cognitive decline or brain structure in this cohort.
  • These findings highlight the importance of monitoring for albuminuria in T2DM patients to identify those at higher risk for cognitive impairment.

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...